Epizyme

EPZM

EPZM
Epizyme Stock Quote
$12.63 -$0.08 -0.6%
Price as of August 14, 2020, 4:30 p.m. EDT View Interactive EPZM Charts

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

Interactive Chart


News & Analysis: Epizyme

All

Market Moves

Earnings